Public meeting of the New Jersey Cannabis Regulatory Commission where the board resumed from executive session, adopted clinical-registrant rules and medical activity reports, approved dozens of licenses and renewals, delegated two authorities to staff, reviewed budget and market data, and heard extensive public comment on testing limits, hemp access, and licensing delays.